117 related articles for article (PubMed ID: 24131921)
1. Gfi1: a unique controller of T(reg) cells.
Shi LZ; Chi H
Cell Cycle; 2013 Dec; 12(23):3581-2. PubMed ID: 24131921
[No Abstract] [Full Text] [Related]
2. GFI1/HDAC1-axis differentially regulates immunosuppressive CD73 in human tumor-associated FOXP3
Roy D; Bose S; Pati S; Guin A; Banerjee K; Saha S; Singhal AK; Chakraborty J; Sarkar DK; Sa G
Eur J Immunol; 2021 May; 51(5):1206-1217. PubMed ID: 33555624
[TBL] [Abstract][Full Text] [Related]
3. In vivo-activated CD103+ Foxp3+ Tregs: of men and mice.
Rötzschke O; Borsellino G; Battistini L; Falk K; Kleinewietfeld M
Blood; 2009 Feb; 113(9):2119-20; author reply 2120. PubMed ID: 19246567
[No Abstract] [Full Text] [Related]
4. Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells.
Zhu J; Davidson TS; Wei G; Jankovic D; Cui K; Schones DE; Guo L; Zhao K; Shevach EM; Paul WE
J Exp Med; 2009 Feb; 206(2):329-41. PubMed ID: 19188499
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory role of the transcription repressor Gfi1 in the generation of thymus-derived regulatory T cells.
Shi LZ; Kalupahana NS; Turnis ME; Neale G; Hock H; Vignali DA; Chi H
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):E3198-205. PubMed ID: 23918371
[TBL] [Abstract][Full Text] [Related]
6. Targeting adenosine and regulatory T cells in cancer immunotherapy.
Churov A; Zhulai G
Hum Immunol; 2021 Apr; 82(4):270-278. PubMed ID: 33610376
[TBL] [Abstract][Full Text] [Related]
7. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC
J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665
[TBL] [Abstract][Full Text] [Related]
8. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function.
Smyth LA; Ratnasothy K; Tsang JY; Boardman D; Warley A; Lechler R; Lombardi G
Eur J Immunol; 2013 Sep; 43(9):2430-40. PubMed ID: 23749427
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells.
Yamazaki S; Steinman RM
J Dermatol Sci; 2009 May; 54(2):69-75. PubMed ID: 19286352
[TBL] [Abstract][Full Text] [Related]
10. The Ets-1 transcription factor controls the development and function of natural regulatory T cells.
Mouly E; Chemin K; Nguyen HV; Chopin M; Mesnard L; Leite-de-Moraes M; Burlen-defranoux O; Bandeira A; Bories JC
J Exp Med; 2010 Sep; 207(10):2113-25. PubMed ID: 20855499
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.
Liu Y; Lan Q; Lu L; Chen M; Xia Z; Ma J; Wang J; Fan H; Shen Y; Ryffel B; Brand D; Quismorio F; Liu Z; Horwitz DA; Xu A; Zheng SG
J Mol Cell Biol; 2014 Feb; 6(1):81-92. PubMed ID: 23861553
[TBL] [Abstract][Full Text] [Related]
12. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
[TBL] [Abstract][Full Text] [Related]
13. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
[TBL] [Abstract][Full Text] [Related]
15. Molecular gastronomy: how to make the critical intestinal Foxp3+ Treg cell.
Cong Y
Gastroenterology; 2011 Nov; 141(5):1559-62. PubMed ID: 21945059
[No Abstract] [Full Text] [Related]
16. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.
Sather BD; Treuting P; Perdue N; Miazgowicz M; Fontenot JD; Rudensky AY; Campbell DJ
J Exp Med; 2007 Jun; 204(6):1335-47. PubMed ID: 17548521
[TBL] [Abstract][Full Text] [Related]
17. Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs.
Yegutkin GG; Auvinen K; Karikoski M; Rantakari P; Gerke H; Elima K; Maksimow M; Quintero IB; Vihko P; Salmi M; Jalkanen S
Mediators Inflamm; 2014; 2014():485743. PubMed ID: 25242869
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric lymph node CD11b
Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
[TBL] [Abstract][Full Text] [Related]
19. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
[TBL] [Abstract][Full Text] [Related]
20. IL-2 prevents deletion of developing T-regulatory cells in the thymus.
Hu DY; Wirasinha RC; Goodnow CC; Daley SR
Cell Death Differ; 2017 Jun; 24(6):1007-1016. PubMed ID: 28362433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
